Cavitation Technologies (Cavitation Technologies) Change In Payables And Accrued Expense : $0.05 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Cavitation Technologies Change In Payables And Accrued Expense?

Cavitation Technologies's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $0.02 Mil. It means Cavitation Technologies's Accounts Payable & Accrued Expense increased by $0.02 Mil from Sep. 2023 to Dec. 2023 .

Cavitation Technologies's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2023 was $-0.02 Mil. It means Cavitation Technologies's Accounts Payable & Accrued Expense declined by $0.02 Mil from Jun. 2022 to Jun. 2023 .

Cavitation Technologies Change In Payables And Accrued Expense Historical Data

The historical data trend for Cavitation Technologies's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cavitation Technologies Change In Payables And Accrued Expense Chart

Cavitation Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-0.12

-0.08

-0.04

-0.02

Cavitation Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															0.03	-0.04	-0.01	0.07	0.02

Cavitation Technologies Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05 Mil.

Cavitation Technologies Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cavitation Technologies's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cavitation Technologies (Cavitation Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Cavitation Technologies Inc (OTCPK:CVAT) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

10019 Canoga Avenue, Chatsworth, CA, USA, 91311

Website

http://www.ctinanotech.com

Cavitation Technologies Inc develops, patents, and commercializes the proprietary technology for large-scale liquid processing applications. The firm has commercialized its proprietary technology for refining vegetable oils by providing domestic and foreign refining facilities with a firm's Nano Neutralization technology and cavitation systems comprising the Nano Reactor. Its technologies can be applied to several other fluid-processing industries that will benefit from increased yields, lowered processing costs, and improved quality. It has filed patent applications related to edible oil refining, renewable fuel production, both alcoholic and non-alcoholic beverage processing and enhancement, and petroleum upgrading. Its component comprises of Nano Reactor and LPN.

Executives

Naum Voloshin	officer: Chief Financial Officer	10019 CANOGA AVENUE, CHATSWORTH CA 91311
Roman Gordon	director, 10 percent owner, officer: CEO, Secretary	10019 CANOGA AVENUE, CHATSWORTH CA 91311
Todd Zelek	director, officer: CEO	730 SOUTH SAN RAFAEL AVENUE, PASADENA CA 91105
James W Fuller	director	C/O BAYTREE CAPITAL ASSOCIATES LLC, 40 WALL STREET, 58TH FLOOR, NEW YORK NY 10005
Igor Gorodnitsky	director, 10 percent owner, officer: President	10019 CANOGA AVENUE, CHATSWORTH CA 91311
R L Hartshorn	director, 10 percent owner, officer: CFO	10019 CANOGA AVENUE, CHATSWORTH CA 91311
Jose Antonio Castro	director, 10 percent owner, officer: CEO & CFO	3702 SOUTH VIRGINIA STREET, #G12-401, RENO NV 89502
Zhang Haiming	director, 10 percent owner, officer: Chief Technology Officer	3702 SOUTH VIRGINIA STREET, #G12-401, RENO NV 89502